Evidence map›Paper›PMID 21145228›Full record

ReviewCurrent opinion in structural biology2011

Regulation of innate immunity through RNA structure and the protein kinase PKR.

Subba Rao Nallagatla, Rebecca Toroney, Philip C Bevilacqua

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in structural biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 136 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Roles and Applications of Circular RNA in Virus Infection.International journal of molecular sciences · 2025
    Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Circular RNA vaccine in disease prevention and treatment.Signal transduction and targeted therapy · 2023
    Review
  15. A highly efficient human cell-free translation system.bioRxiv : the preprint server for biology · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Genome-encoded cytoplasmic double-stranded RNAs, found inScience translational medicine · 2021
    Article
  20. Review

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Subba Rao NallagatlaDepartment of Chemistry, The Pennsylvania State University, 104 Chemistry Bldg, University Park, PA 16802, USA.
Rebecca Toroney
Philip C Bevilacqua
Pennsylvania State University · US

Funding

Regulation of PKR by Novel RNA MotifsR01GM058709 · NIGMS · PENNSYLVANIA STATE UNIVERSITY-UNIV PARK · PI BEVILACQUA, PHILIP C · 1999 to 2012
$2.8M
NIGMS NIH HHS R01 GM058709PHS HHS R01-58709
6 · The paper itself

Abstract

Molecular recognition of RNA structure is key to innate immunity. The protein kinase PKR differentiates self from non-self by recognition of molecular patterns in RNA. Certain biological RNAs induce autophosphorylation of PKR, activating it to phosphorylate eukaryotic initiation factor 2α (eIF2α), which leads to inhibition of translation. Additional biological RNAs inhibit PKR, while still others have no effect. The aim of this article is to develop a cohesive framework for understanding and predicting PKR function in the context of diverse RNA structure. We present effects of recently characterized viral and cellular RNAs on regulation of PKR, as well as siRNAs. A central conclusion is that assembly of accessible long double-stranded RNA (dsRNA) elements within biological RNAs plays a key role in regulation of PKR kinase. Strategies for forming such elements include RNA dimerization, formation of symmetrical helical defects, A-form dsRNA mimicry, and coaxial stacking of helices.

Indexed as

Immunity, InnateNucleic Acid ConformationAnimalseIF-2 KinaseEnzyme ActivationHumansRNAeIF-2 KinaseRNA

Identifiers

PMID21145228
PMCPMC3075410
OpenAlexW2141760092

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.